COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #45
Source   PDF   Share   Tweet
See all 146 studies
5/28
Positive
Late treatment study
Huang et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113 (Peer Reviewed)
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of ch loroquine for the treatment of COVID-19
197 C Q patients, 176 control. Mean time to undetectable viral RNA and duration of fever significantly reduced. No serious adverse events.
time to viral-, ↓67.0%, p<0.0001
Source   PDF   Share   Tweet
See all 146 studies
Please send us corrections, updates, or comments.
Submit